NDC 33342-313 – Memantine and Donepezil
Memantine Hydrochloride 28 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Oral
Product NDC33342-313
Product details
- Brand name
- Memantine and Donepezil
- Generic name
- Memantine and Donepezil
- Labeler
- Macleods Pharmaceuticals Limited
- Dosage form
- Capsule, Extended Release
- Route
- Oral
- Marketing category
- ANDA · ANDA208672
- Marketed since
- July 15, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Cholinesterase Inhibitor; N-methyl-D-aspartate Receptor Antagonist
Active ingredients
- Memantine Hydrochloride 28 mg/1
- Donepezil Hydrochloride 10 mg/1
Uses, dosage, side effects and warnings for Memantine and Donepezil →
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 33342-313-07 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-313-07) | Jul 15, 2025 |
| 33342-313-10 | 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (33342-313-10) | Jul 15, 2025 |
| 33342-313-56 | 10 BLISTER PACK in 1 CARTON (33342-313-56) / 14 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK | Jul 15, 2025 |
Other Memantine and Donepezil products
- 33342-312 Memantine Hydrochloride 14 mg/1; Donepezil Hydrochloride 10 mg/1 · Capsule, Extended Release · Macleods Pharmaceuticals Limited